Application Type
Patent
Application SubType
PCT National Phase
(10) Registration Number and Date
BNN20180103 10.12.2019
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
BN N/2018/0103 12.05.2017
(40) Publication Number and Date
BN N/2018/0103
A
10.12.2019
(86) PCT Filing Number and Date
(87) PCT Publication Number and Date
(85) National Entry Date
(30) Priority Details
US 62/336,129
13.05.2016
(51) IPC Classes
(71/73) Applicant
(72) Inventor
(EN) EMTAGE, Peter : c/o Cell Design Labs QB3@953 Indiana Street San Francisco, CA 94107
(74) Representative Name
(EN) Ahmad Isa & Partners : Unit Nos. 404A-410A 4th Floor, Wisma Jaya Jalan Pemancha Bandar Seri Begawan BS8811
(54) Title
(EN) CD40L-FC FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
(57) Abstract
(EN)
Provided herein is a CD40L-Fc fusion protein and methods of using the fusion protein in the treatment of cancer comprising administering the CD40L-Fc fusion protein or the CD40L-Fc fusion protein in combination with one or more immune checkpoint inhibitors (e.g., an anti-CTLA4 antibody, anti-PD-Ll antibody).
--
(58) Citations